Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,001 | 94,172 | 86,052 | 151,632 | 132,542 |
| Marketable Securities | 272,533 | 295,218 | 290,592 | 240,104 | 286,210 |
| Receivables | 19,046 | 13,483 | 41,771 | 18,173 | 20,401 |
| Inventories | 31,745 | 24,752 | 25,320 | 25,863 | 26,266 |
| Other current assets | 1,227 | 1,334 | 3,808 | 1,088 | 3,966 |
| TOTAL | $423,648 | $442,539 | $459,702 | $453,193 | $477,618 |
| Non-Current Assets | |||||
| PPE Net | 8,655 | 8,557 | 8,703 | 9,262 | 9,564 |
| Intangibles | 6,101 | 6,425 | 6,839 | 7,338 | 7,882 |
| Other Non-Current Assets | 13,357 | 13,339 | 13,049 | 12,355 | 11,838 |
| TOTAL | $28,113 | $28,321 | $28,591 | $28,955 | $29,284 |
| Total Assets | $451,761 | $470,860 | $488,293 | $482,148 | $506,902 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,680 | 3,087 | N/A | N/A | 3,267 |
| Accrued Expenses | 31,225 | 36,278 | 40,057 | 31,559 | 29,060 |
| Other current liabilities | 1,979 | 2,033 | 724 | 1,293 | 502 |
| TOTAL | $42,046 | $46,107 | $41,765 | $34,626 | $33,838 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,157 | 3,148 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,321 | 12,166 | 15,833 | 16,323 | 17,379 |
| TOTAL | $19,307 | $19,318 | $23,103 | $23,754 | $24,941 |
| Total Liabilities | $61,353 | $65,425 | $64,868 | $58,380 | $58,779 |
| Shareholders' Equity | |||||
| Common Shares | 1,193,019 | 1,185,309 | 1,184,020 | 1,180,884 | 1,178,807 |
| Retained earnings | -890,508 | -864,302 | -838,256 | -829,267 | -793,752 |
| Other shareholders' equity | -988 | -1,061 | -1,527 | -1,853 | -1,618 |
| TOTAL | $390,408 | $405,435 | $423,425 | $423,768 | $448,123 |
| Total Liabilities And Equity | $451,761 | $470,860 | $488,293 | $482,148 | $506,902 |